Delivery Order SPE2DB22D1017-SPE2DB24FF3BV
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,441.01 delivery order is for the pharmaceutical product "XULANE 150-35 MCG/DAY PATCH 3S" and has an ultimate completion date of January 18, 2022. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,596.76 Firm Fixed Price delivery order is for the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract has an ultimate completion date of December 8, 2023 and was awarded on December 7, 2023. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $4,563.96 Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA). The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) the DLA has with Cencora, Inc. valued at up to $999,999,999.00, which covers a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,491.50 delivery order is for the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The award is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award for $1,543.83 was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a completion date of May 14, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The $1,612.53 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive patch, with a period of performance through January 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award, valued at $7,664.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a completion date of February 5, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,234.59, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of September 19, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $1,539.91 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of the prescription drug XULANE 150-35 MCG/DAY PATCH 3S. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,355.75 firm fixed-price delivery order is for the pharmaceutical product Xulane 150-35 mcg/day patch, a contraceptive medication. The contract has an ultimate completion date of May 22, 2023 and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF3BVDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,075.04 firm fixed-price delivery order is for the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The ultimate completion date for this award is February 22, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 2/21/24 |